TG THERAPEUTICS, INC. Short-term Investments
TG THERAPEUTICS, INC. (TGTX) had Short-term Investments of $69.67 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-05
- 2026-06-30: Short-term Investments $69.67M.
- 2026-03-31: Short-term Investments $72.22M.
- 2025-12-31: Short-term Investments $62.82M.
- 2025-09-30: Short-term Investments $57.50M.
| Period end | Short-term Investments | Short-term Investments as first filed |
|---|---|---|
| 2026-06-30 | $69.67M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $72.22M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $62.82M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $57.50M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $122.74M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $144.10M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $131.11M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $145.22M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $134.34M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $134.31M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $124.58M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $78.26M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $47.90M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $78.24M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $59.37M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $66.08M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $48.64M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $47.52M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $15.88M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $30.34M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $41.75M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $52.33M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $51.99M 10-K · filed 2022-03-01 | |
| 2020-06-30 | $15.06M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $26.28M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $27.80M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $27.78M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $27.75M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $28.13M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $26.94M 10-K · filed 2020-03-02 | $26.85M 10-K · filed 2019-03-01 |
| 2018-09-30 | $27.02M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $20.57M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $26.18M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $28.00M 10-K · filed 2019-03-01 | $28.00M 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.81M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $13.82M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $19.85M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $31.45M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $25.68M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $22.22M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $22.17M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $28.70M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $31.77M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $19.13M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $23.06M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $14.01M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $7.96M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $3.90M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |